Correlation Between Nascent Wine and CERo Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nascent Wine and CERo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nascent Wine and CERo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nascent Wine and CERo Therapeutics Holdings, you can compare the effects of market volatilities on Nascent Wine and CERo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nascent Wine with a short position of CERo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nascent Wine and CERo Therapeutics.

Diversification Opportunities for Nascent Wine and CERo Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Nascent and CERo is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Nascent Wine and CERo Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CERo Therapeutics and Nascent Wine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nascent Wine are associated (or correlated) with CERo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CERo Therapeutics has no effect on the direction of Nascent Wine i.e., Nascent Wine and CERo Therapeutics go up and down completely randomly.

Pair Corralation between Nascent Wine and CERo Therapeutics

If you would invest  7.00  in CERo Therapeutics Holdings on October 9, 2024 and sell it today you would lose (5.61) from holding CERo Therapeutics Holdings or give up 80.14% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy34.55%
ValuesDaily Returns

Nascent Wine  vs.  CERo Therapeutics Holdings

 Performance 
       Timeline  
Nascent Wine 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nascent Wine has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Nascent Wine is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
CERo Therapeutics 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in CERo Therapeutics Holdings are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, CERo Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Nascent Wine and CERo Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nascent Wine and CERo Therapeutics

The main advantage of trading using opposite Nascent Wine and CERo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nascent Wine position performs unexpectedly, CERo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CERo Therapeutics will offset losses from the drop in CERo Therapeutics' long position.
The idea behind Nascent Wine and CERo Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets